Sight Diagnostics raises $71M Series D for its blood analyzer -- MEDICA - World Forum for Medicine

05.08.2020

S.D Sight Diagnostics Ltd.

Sight Diagnostics raises $71M Series D for its blood analyzer

Sight Diagnostics, the Israel-based health-tech company behind the FDA-cleared OLO blood analyzer, announced that it raised a $71 million Series D round with participation from Koch Disruptive Technologies, Longliv Ventures (which led theSeries C round) and crowd-funding platform OurCrowd. With this, the company has now raised a total of $124 million.

Exhibitor Data Sheet